home / stock / phge / phge news

PHGE News and Press, Chardan Healthcare Acquisition Corp.

Stock Information
Company Name: Chardan Healthcare Acquisition Corp.
Stock Symbol: PHGE
Market: NYSE
Menu
PHGE PHGE Quote PHGE Short PHGE News PHGE Articles PHGE Message Board
Get PHGE Alerts

News, Short Squeeze, Breakout and More Instantly...
PHGE - BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today annou...
PHGE - BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conference and at ASM Microbe 2024

GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today annou...

PHGE - BiomX (PHGE) Q1 2024 Earnings Call Transcript

2024-05-21 10:25:27 ET BiomX Inc. (PHGE) Q1 2024 Earnings Conference Call May 21, 2024 8:00 am ET Company Participants Jonathan Solomon - Chief Executive Officer Avi Gabay - Chief Financial Officer Conference Call Participants Joe Pantginis - HC Wainwrigh...

PHGE - BiomX GAAP EPS of -$0.28

2024-05-21 06:32:57 ET More on BiomX BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript BiomX surges on merger deal with Adaptive Phage Seeking Alpha’s Quant Rating on BiomX Historical earnings data for BiomX Financial information for BiomX ...
PHGE - BiomX Reports First Quarter 2024 Financial Results and Provides Business and Program Updates

Following merger with Adaptive Phage Therapeutics in March, combined company reports funding sufficient to support important data readouts for lead clinical programs in 2025 Company will host a conference call and webcast today at 8:00 am ET GAITHERSBURG, Md. and NESS ZIONA, Israel, M...

PHGE - BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024

GAITHERSBURG, Maryland and NESS ZIONA, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today ...

PHGE - BiomX files to sell 120.15M warrants for holders

2024-04-29 16:43:20 ET More on BiomX BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript BiomX surges on merger deal with Adaptive Phage Seeking Alpha’s Quant Rating on BiomX Historical earnings data for BiomX Financial information for BiomX ...
PHGE - BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 23, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today anno...

PHGE - BiomX Announces the Appointment of Susan Blum to its Board of Directors

CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today anno...

PHGE - BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure

CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 04, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that, as previously discl...
Next 10